Financials Naba Al Saha Medical Services Company
Equities
9546
SA15K0SKL513
Healthcare Facilities & Services
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
85.2 SAR | -2.07% | -3.73% | +42.00% |
Mar. 31 | Naba Al Saha Medical Services Posts Higher FY23 Profit, Revenue | MT |
Mar. 18 | Naba Al Saha Medical Services Renews Hospital Accreditation | MT |
Valuation
Fiscal Period: December | 2022 |
---|---|
Capitalization 1 | 301 |
Enterprise Value (EV) 1 | 309.2 |
P/E ratio | 11.2 x |
Yield | 0.7% |
Capitalization / Revenue | 2.32 x |
EV / Revenue | 2.38 x |
EV / EBITDA | 8.97 x |
EV / FCF | 19,769,559 x |
FCF Yield | 0% |
Price to Book | 2.32 x |
Nbr of stocks (in thousands) | 10,500 |
Reference price 2 | 28.67 |
Announcement Date | 4/4/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 |
---|---|---|---|
Net sales 1 | 115.7 | 117.7 | 129.7 |
EBITDA 1 | 32.18 | 31.5 | 34.49 |
EBIT 1 | 27.57 | 26.85 | 29.29 |
Operating Margin | 23.83% | 22.82% | 22.59% |
Earnings before Tax (EBT) 1 | 28.34 | 27.53 | 28.93 |
Net income 1 | 26.65 | 25.83 | 26.92 |
Net margin | 23.04% | 21.95% | 20.76% |
EPS | - | 2.460 | 2.564 |
Free Cash Flow | - | 14.29 | 15.64 |
FCF margin | - | 12.14% | 12.06% |
FCF Conversion (EBITDA) | - | 45.36% | 45.36% |
FCF Conversion (Net income) | - | 55.33% | 58.1% |
Dividend per Share | - | 0.2000 | 0.2000 |
Announcement Date | 7/31/22 | 7/31/22 | 4/4/23 |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 |
---|---|---|---|
Net Debt 1 | 47.5 | 26.3 | 8.24 |
Net Cash position 1 | - | - | - |
Leverage (Debt/EBITDA) | 1.478 x | 0.8349 x | 0.2391 x |
Free Cash Flow | - | 14.3 | 15.6 |
ROE (net income / shareholders' equity) | - | 28.5% | 23.1% |
ROA (Net income/ Total Assets) | - | 11.1% | 11.1% |
Assets 1 | - | 233.5 | 241.7 |
Book Value Per Share | - | 9.800 | 12.40 |
Cash Flow per Share | - | 0.6700 | 1.320 |
Capex 1 | 39.6 | 10.4 | 7.55 |
Capex / Sales | 34.27% | 8.81% | 5.82% |
Announcement Date | 7/31/22 | 7/31/22 | 4/4/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+42.00% | 244M | |
+17.73% | 83.46B | |
-32.08% | 67.33B | |
-2.32% | 25.66B | |
+3.56% | 17.91B | |
-13.68% | 16.54B | |
+0.75% | 15.43B | |
+74.92% | 13.46B | |
+73.16% | 12.78B | |
-2.02% | 12.33B |
- Stock Market
- Equities
- 9546 Stock
- Financials Naba Al Saha Medical Services Company